Although the majority of patients are diagnosed with early-stage disease, outcomes remain poor for those with primary advanced or recurrent endometrial cancer, with reported 5-year survival rates as ...
Undetectable RAS-Mutant Clones in Plasma: Possible Implication for Anti-EGFR Therapy and Prognosis in Patients With RAS-Mutant Metastatic Colorectal Cancer To predict MMR-D, we adapted methods ...
NORTHFIELD, Ill.--(BUSINESS WIRE)--Recognizing a need for evidence-based recommendations to guide molecular testing in the management of patients with cancer, the College of American Pathologists (CAP ...
Based on the pivotal role of dMMR/MSI-H status in treatment selection for CRC, the National Comprehensive Cancer Network® (NCCN®) guidelines for colon and rectal cancer recommend universal MMR or MSI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results